To evaluate the efficacy of the test product in providing Anti- Ageing Benefits in Healthy Human Volunteers - NI

Ichimaru Pharcos Co Ltd0 sites38 target enrollmentStarted: TBDLast updated: June 24, 2024

Trial Snapshot

No summary available.

•1. Subjects in the age group of 20-55 years (both ages inclusive).
•2. Subject presenting at least 2 well defined dark spots of PIH/Acne/Age spots on either side of the face.
•3. Subject identified for fine lines of score 4 and above and wrinkles of score 2 and above
•4. Subjects with skin phototype III to V. (10% of the subjects to be phototype V).
•5. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face as determined by the dermatologist.
•6. Subject who agrees not to use any other product/treatment/home remedy/ except the provided product on their face during the study period other than the test product.

•1.Subject with any other signs of significant local irritation or skin disease.
•2. Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
•3. Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year.
•4. Subjects undergoing any treatment of any skin condition on their face.
•5. Subjects not willing to discontinue other topical facial products.
•6. Subject allergic or sensitive to bar, cleansing products, cosmetics, creams/lotions, artificial jewelry or anything else.
•7. Subjects who are pregnant and lactating (Self- declared).
•8. Subject who has participated in a similar clinical investigation in the past one month.

Sponsor